Living Donor Liver Transplantation in a Hepatitis B Patient with Acute on Chronic Liver Failure Accompanying Hepatocellular Carcinoma.
10.12771/emj.2016.39.3.76
- Author:
Hee Jin HONG
1
;
Joo Ho LEE
;
Yun Bin LEE
;
Hana PARK
;
Seong Gyu HWANG
;
Kyu Sung RIM
Author Information
1. Department of Internal Medicine, CHA Bundang Medical Center, CHA University, Seongnam, Korea. piolee2000@naver.com
- Publication Type:Case Report
- Keywords:
Hepatocellular carcinoma;
Chronic hepatitis B;
Acute liver failure;
Liver transplantation;
Milan criteria
- MeSH:
Acute-On-Chronic Liver Failure*;
Carcinoma, Hepatocellular*;
Hepatitis B*;
Hepatitis B, Chronic;
Hepatitis*;
Humans;
Liver Cirrhosis;
Liver Diseases;
Liver Failure;
Liver Failure, Acute;
Liver Transplantation*;
Liver*;
Living Donors*;
Survival Rate;
Tissue Donors;
Transplants
- From:The Ewha Medical Journal
2016;39(3):76-80
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Acute clinical deterioration in patients with chronic liver disease is called acute on chronic liver failure (ACLF). Principles of management of ACLF consist of early identifying etiology of liver disease, rapid intervention of precipitating event and discreet intensive cares. Despite medical intensive cares, if liver failure progresses, liver transplantation could be the other option. Also, liver transplantation is the only treatment that offers a chance of cure for hepatocellular carcinoma (HCC) and the underlying liver cirrhosis simultaneously. Emergent living donor liver transplantation (LDLT) can be performed for patients with acute liver failure and improves survival rate, especially in circumstances which liver graft is often not available because of deceased donors are not affordable. Here, we describe a chronic hepatitis B patient who developed ACLF accompanying early HCC. Because he did not improved with medical care, he received emergent LDLT. After LDLT, he showed great improvement without critical complications.
